NDC 76329-3469-01 - Naloxone Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 76329-3469
- Requested NDC
- 76329-3469-01
- Package NDCs from labels
- 76329-3469-1, 76329-3469-01
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2022-02-02
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Naloxone Hydrochloride - REMEDYREPACK INC. | REMEDYREPACK INC. | 2022-02-02 | HUMAN PRESCRIPTION DRUG LABEL |
| Naloxone Hydrochloride - International Medication Systems, Limited | International Medication Systems, Limited | 2021-12-13 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 76329-3469-1 | Naloxone Hydrochloride | 2 mL in 1 SYRINGE | INJECTION | 2 | 3 | |
| 76329-3469-1 | Naloxone Hydrochloride | 10 in 1 BOX | INJECTION | 10 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 76329-3469 | NALOXONE HYDROCHLORIDE INJECTION [INTERNATIONAL MEDICATION SYSTEMS, LIMITED ] | 3 | Current NDC, Legacy NDC, 2 package rows | 20211216_d2f5bfa0-933e-46d0-8b1a-9f90e6aaba54.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| pentazocine and naloxone | PENTAZOCINE AND NALOXONE | Sun Pharmaceutical Industries, Inc. | 41ebdaaf-3bbc-419f-b996-0341efc14623 | 2018-07-31 | Boxed warning, Warnings, Adverse reactions | F850569PQR |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.